Wird geladen...
Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal Cancer
Nearly 45% of colorectal cancer (CRC) patients harbor a mutation in their <i>KRAS</i> gene for which, despite many years of research, there are still no targeted therapies available. Protein Arginine Methyltransferase 5 (PRMT5) is a transcription regulator for multiple cellular processes...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2020-07-01
|
| Schriftenreihe: | Cancers |
| Schlagworte: | |
| Online Zugang: | https://www.mdpi.com/2072-6694/12/8/2091 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|